HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$3.12
Day range
$3.06 - $3.16
Year range
$2.75 - $4.60
Market cap
261.84M USD
Avg Volume
456.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.04M | -12.38% |
Net income | -31.15M | 6.01% |
Net profit margin | — | — |
Earnings per share | -0.37 | 7.50% |
EBITDA | -30.86M | -0.99% |
Effective tax rate | -0.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 482.81M | -18.87% |
Total assets | 490.96M | -19.26% |
Total liabilities | 32.44M | 23.12% |
Total equity | 458.52M | — |
Shares outstanding | 84.46M | — |
Price to book | 0.57 | — |
Return on assets | -15.46% | — |
Return on capital | -16.49% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -31.15M | 6.01% |
Cash from operations | -23.04M | -30.95% |
Cash from investing | -122.01M | -108.52% |
Cash from financing | 117.00K | 27.17% |
Net change in cash | -144.93M | -90.67% |
Free cash flow | -8.46M | -1,463.59% |
About
Founded
2012
Headquarters
Website
Employees
75
